Table 1B.
Patient follow-up characteristics overall and by glomerular cluster
| Total (n=221) | Cluster X (n=56) | Cluster Y (n=68) | Cluster Z (n=97) | |
|---|---|---|---|---|
|
| ||||
| Follow-up time (years), median (Q1, Q3) | 4.17 (2.25, 4.67) | 3.08 (2.04, 4.54) | 4.50 (2.63, 4.75) | 4.17 (2.33, 4.58) |
| Number of complete remission events | 107 | 18 | 38 | 51 |
| Rate of complete remission (# of events per 100 person-years) a | 34.8 | 17.8 | 30.8 | 61.1 |
| Number of disease progression (≥40% decline in eGFR with eGFR<90 or kidney failure) events | 30 | 19 | 8 | 3 |
| Rate of disease progression (# of events per 100 person-years) b | 4.8 | 15.9 | 3.6 | 1.1 |
Q1, first quartile; Q3, third quartile
a
n=181 (n=25 had complete remission at biopsy; n=9 missing UPCR at biopsy; n=6 had no follow-up UPCR)
b
n=193 (n=22 missing eGFR at biopsy; n=6 had no follow-up eGFR)